InsiderTrades

Form 4 for LSTA LISATA THERAPEUTICS, INC.

Accepted 2021-09-03 00:00:00 ET · period of report 2021-09-01 · accession 0001879231-21-000006 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-09-03 2021-09-01 LSTA Buck Kristen K EVP, CMO, R, D A - Grant $0.00 +312.5K 312.5K New $0
D 2021-09-03 2021-09-01 LSTA Buck Kristen K EVP, CMO, R, D F - Tax $1.28 -50.1K 262.4K -16% -$64.1K
D 2021-09-03 2021-09-01 LSTA Buck Kristen K EVP, CMO, R, D A - Grant $0.00 +1.14M 1.14M New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-09-01 A A 312,500 $0.00 312,500 D — — (F1) Represents 312,500 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in three equal installments, with one-third of the shares vesting on the date of grant and an additional one-third vesting on each of the first and second annual anniversaries of the grant date.
2 Common Common Stock 2021-09-01 F D 50,103 $1.28 262,397 D — — (F2) Includes 209,375 unvested restricted stock awards.
3 Derivative Stock Option (Right to Buy) 2021-09-01 A A 1,137,915 $0.00 1,137,915 D $1.28 · 2021-09-01 to 2031-09-01 1,137,915 Common Stock (F3) One-third of the shares underlying the stock options vest immediately on the grant date, with an additional one-third vesting on each of the first and second annual anniversaries of the grant date.